Simultaneous reduction of flow and fraction of inspired oxygen (FiO2) versus reduction of flow first or FiO2 first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial)
Abstract Background High-flow nasal cannula (HFNC) oxygen therapy has been widely used in critically ill patients. Despite the effectiveness of HFNC as a treatment, optimal methods to withdraw HFNC after recovery from preexisting conditions have not been investigated to date. In this study, we will...
Main Authors: | Min Chul Kim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Choon-Taek Lee, Jae Ho Lee, Eun Sun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-019-4019-7 |
Similar Items
-
Oxygen supplementation via high-flow nasal cannula is an effective treatment for pneumocephalus
by: Deok-Soo Lee, et al.
Published: (2019-12-01) -
Clinical studies with high flow nasal cannula oxygen delivery in 2015
by: David Sotello, et al.
Published: (2016-04-01) -
Weaning from mechanical ventilation with high flow oxygen therapy via tracheal cannula
by: Kristijan Skok, et al.
Published: (2021-02-01) -
The importance of high flow nasal cannula (HFNC) oxygen therapy
by: TIGLIS Mirela, et al.
Published: (2019-03-01) -
High Flow Nasal Cannula Therapy for Improving Obstructive Sleep Apnea: A Case Report
by: Se Joong Kim, et al.
Published: (2015-06-01)